title: [Long-term results of adjuvant endocrine therapy for hormone receptor-positive breast cancer].
authors.forename: V F
authors.initials: VF
authors.lastname: Semilgazov
authors.forename: A G
authors.initials: AG
authors.lastname: Manikhas
authors.forename: V V
authors.initials: VV
authors.lastname: Semiglazov
authors.forename: A A
authors.initials: AA
authors.lastname: Bozhok
authors.forename: G A
authors.initials: GA
authors.lastname: Dashian
authors.forename: V G
authors.initials: VG
authors.lastname: Ivanov
authors.forename: R M
authors.initials: RM
authors.lastname: Paltuev
authors.forename: A G
authors.initials: AG
authors.lastname: Vasil'ev
authors.forename: D E
authors.initials: DE
authors.lastname: Shchedrin
authors.forename: A M
authors.initials: AM
authors.lastname: Ermachenkova
authors.forename: I V
authors.initials: IV
authors.lastname: Nikitina
authors.forename: K D
authors.initials: KD
authors.lastname: Pen'kov
authors.forename: A A
authors.initials: AA
authors.lastname: Bessonov
authors.forename: T T
authors.initials: TT
authors.lastname: Tabagua
authors.forename: V V
authors.initials: VV
authors.lastname: Kolar'kova
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000737:chemistry / Q000188:drug therapy*; D017697:Premenopause; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen